Login / Signup

Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome.

Magdy El-SalhyOdd Helge GiljaJan Gunnar Hatlebakk
Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2023)
gov: NCT04236843).
Keyphrases
  • irritable bowel syndrome
  • cell therapy
  • bone marrow
  • mesenchymal stem cells